| 1 |
Demirag AD, Çelik S, Arslan S, Özel A, Akyüz S. The inhibitory activity of Ruxolitinib against COVID-19 major protease enzyme and SARS CoV-2 spike glycoprotein: A molecular docking study. ojn 2023;8:1-9. [DOI: 10.56171/ojn.1134119] [Reference Citation Analysis]
|
| 2 |
Omage FB, Madabeni A, Tucci AR, Nogara PA, Bortoli M, Rosa ADS, Neuza Dos Santos Ferreira V, Teixeira Rocha JB, Miranda MD, Orian L. Diphenyl Diselenide and SARS-CoV-2: in silico Exploration of the Mechanisms of Inhibition of Main Protease (M(pro)) and Papain-like Protease (PL(pro)). J Chem Inf Model 2023. [PMID: 36952618 DOI: 10.1021/acs.jcim.3c00168] [Reference Citation Analysis]
|
| 3 |
Li J, Wang Y, Solanki K, Atre R, Lavrijsen M, Pan Q, Baig MS, Li P. Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses. Antiviral Res 2023;211:105555. [PMID: 36791846 DOI: 10.1016/j.antiviral.2023.105555] [Reference Citation Analysis]
|
| 4 |
Duong CQ, Nguyen PTV. Exploration of SARS-CoV-2 Mpro Noncovalent Natural Inhibitors Using Structure-Based Approaches. ACS Omega 2023;8:6679-88. [PMID: 36844600 DOI: 10.1021/acsomega.2c07259] [Reference Citation Analysis]
|
| 5 |
Eberle RJ, Sevenich M, Gering I, Scharbert L, Strodel B, Lakomek NA, Santur K, Mohrlüder J, Coronado MA, Willbold D. Discovery of All-d-Peptide Inhibitors of SARS-CoV-2 3C-like Protease. ACS Chem Biol 2023;18:315-30. [PMID: 36647580 DOI: 10.1021/acschembio.2c00735] [Reference Citation Analysis]
|
| 6 |
Salimi YK, Aman LO, Wathoni Z, Ischak NI, La Kilo A, Alio L. Screening of Secondary Metabolite Compounds of Gorontalo Traditional Medicinal Plants Using the In Silico Method as a Candidate for SARS-CoV-2 Antiviral. J Kim Sains Apl 2023;25:382-393. [DOI: 10.14710/jksa.25.10.382-393] [Reference Citation Analysis]
|
| 7 |
Silva RS, Souza LMP, Costa RKM, Souza FR, Pimentel AS. Absolute binding free energies of the antiviral peptide ATN-161 with protein targets of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 2022. [DOI: 10.1080/07391102.2022.2154848] [Reference Citation Analysis]
|
| 8 |
Patel CN, Jani SP, Prasanth Kumar S, Modi KM, Kumar Y. Computational investigation of natural compounds as potential main protease (M(pro)) inhibitors for SARS-CoV-2 virus. Comput Biol Med 2022;151:106318. [PMID: 36423529 DOI: 10.1016/j.compbiomed.2022.106318] [Reference Citation Analysis]
|
| 9 |
Fatriansyah JF, Boanerges AG, Kurnianto SR, Pradana AF, Fadilah, Surip SN. Molecular Dynamics Simulation of Ligands from Anredera cordifolia (Binahong) to the Main Protease (Mpro) of SARS-CoV-2. Journal of Tropical Medicine 2022;2022:1-13. [DOI: 10.1155/2022/1178228] [Reference Citation Analysis]
|
| 10 |
Ávila-Gálvez MÁ, Rafael-Pita C, Fernández N, Baixinho J, Anastácio JD, Cankar K, Bosch D, Nunes Dos Santos C. Targeting proteases involved in the viral replication of SARS-CoV-2 by sesquiterpene lactones from chicory (Cichorium intybus L.). Food Funct 2022;13:8977-88. [PMID: 35938740 DOI: 10.1039/d2fo00933a] [Reference Citation Analysis]
|
| 11 |
Alvarado YJ, Olivarez Y, Lossada C, Vera-Villalobos J, Paz JL, Vera E, Loroño M, Vivas A, Torres FJ, Jeffreys LN, Hurtado-León ML, González-Paz L. Interaction of the new inhibitor paxlovid (PF-07321332) and ivermectin with the monomer of the main protease SARS-CoV-2: A volumetric study based on molecular dynamics, elastic networks, classical thermodynamics and SPT. Comput Biol Chem 2022;99:107692. [PMID: 35640480 DOI: 10.1016/j.compbiolchem.2022.107692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Antonopoulou I, Sapountzaki E, Rova U, Christakopoulos P. The Inhibitory Potential of Ferulic Acid Derivatives against the SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and ADMET Evaluation. Biomedicines 2022;10:1787. [DOI: 10.3390/biomedicines10081787] [Reference Citation Analysis]
|
| 13 |
Issa SS, Sokornova SV, Zhidkin RR, Matveeva TV. The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus. Plants 2022;11:1862. [DOI: 10.3390/plants11141862] [Reference Citation Analysis]
|
| 14 |
Mohammed AO, Abo-idrees MI, Makki AA, Ibraheem W, Alzain AA. Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics. Struct Chem. [DOI: 10.1007/s11224-022-01999-9] [Reference Citation Analysis]
|
| 15 |
Feng J, Li D, Zhang J, Yin X, Li J. Crystal structure of SARS-CoV 3C-like protease with baicalein. Biochemical and Biophysical Research Communications 2022;611:190-4. [DOI: 10.1016/j.bbrc.2022.04.086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Aljuhani A, Ahmed HEA, Ihmaid SK, Omar AM, Althagfan SS, Alahmadi YM, Ahmad I, Patel H, Ahmed S, Almikhlafi MA, El-agrody AM, Zayed MF, Turkistani SA, Abulkhair SH, Almaghrabi M, Salama SA, Al-karmalawy AA, Abulkhair HS. In vitro and computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-M Pro inhibitors. RSC Adv 2022;12:26895-907. [DOI: 10.1039/d2ra04015h] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
|
